Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1476322Generated: October 31, 2026

(R)-4-(4-((tert-Butyldimethylsilyloxy)(4'-chlorobiphenyl-2-yl)methyl)piperidin-1-yl)benzoic acid → HCID 86661878, compound

https://huagongshe.com/reaction/1476322

Reaction equation

Participants

RoleNameHCIDCharge
Reactant(R)-4-(4-((tert-Butyldimethylsilyloxy)(4'-chlorobiphenyl-2-yl)methyl)piperidin-1-yl)benzoic acidHCID 58080201—
ReactantHCID 66723790HCID 66723790—
ProductHCID 86661878HCID 8666187866%

Reaction Steps

The title product (77 mg, 66%) was prepared using a procedure similar to the one described for the synthesis of INTERMEDIATE 33. (R)-4-(4-((tert-Butyldimethylsilyloxy)(4′-chlorobiphenyl-2-yl)methyl)piperidin-1-yl)benzoic acid (INTERMEDIATE 13, 51.7 mg, 0.10 mmol) and 4-((R)-4-((R)-2-((tert-butyldiphenylsilyloxy)methyl)morpholino)-1-(phenylthio)butan-2-ylamino)-3-(trifluoromethyl sulfonyl)benzenesulfonamide (INTERMEDIATE 98, 72 mg, 0.09 mmol) were used as starting materials. The title product was used in the preparation of EXAMPLE 22 without further purification.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09018381B2
Source datasetuspto-grants-2015_04
ORD IDord-5306755aa44d4eb8b963398d76de4c7a
Source noteuspto-grants-2015_04